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Transient receptor potential (TRP) cation channels have been
extensively investigated as targets for analgesic drug discovery.
Because some non-steroidal anti-inﬂammatory drugs (NSAIDs) are
structural analogs of prostaglandins (mediators of inﬂammation)
and NSAIDs attenuate heat nociception and mechanical allodynia
in models of inﬂammatory and neuropathic pain, we examined
three widely used NSAIDs (diclofenac, ketorolac, and xefocam) on
the activation of TRPA1 and TRPV1 channels using thermal paw
withdrawal (Hargreaves) test and mechanical paw withdrawal
(von Frey) test in male rats. Thermal withdrawal latencies and
mechanical thresholds for both hind paws were obtained with 5,
15, 30, 45, 60, and 120 min intraplantar post-injection of TRPA1
agonizts, allyl isothiocyanate (AITC) (a natural compound of mus-
tard oil) and cinnamaldehyde (CA), and TRPV1 agonist capsaicin or
vehicle. Twenty minutes prior to the start of the experiment with
TRP agonizts, diclofenac, ketorolac or xefocamwere pre-injected in
the same hindpaw and animals were examined by these two tests.
After pretreatment of all three NSAIDs in the ipsilateral (injected)
hindpaw that produced strong antinociceptive effects, AITC, CA,
and capsaicin caused signiﬁcant decreases in latency of the ther-
mal withdrawal reﬂex compared with vehicle or the contralateral
hindpaw. The same ﬁndings were observed for the paw with-
drawal threshold. In approximately 30 min the effects of CA, AITC,
and capsaicin returned to baseline. The data are different from our
previous evidence, where TRPA1 agonizts AITC and CA and TRPV1
agonist capsaicin produced hyperalgesia for nearly 2 h and resul-
ted in facilitation of these withdrawal reﬂexes (Tsagareli et al.,vier Inc. This is an open access article under the CC BY license
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I. Nozadze et al. / Data in Brief 6 (2016) 668–673 6692010, 2013). Thus, our data showing that NSAIDs suppress thermal
and mechanical hyperalgesia following TRP activation could pre-
sumably due to inactivation or desensitization of TRPA1 and TRPV1
channels by NSAIDs.
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Value of the data
 We examined three widely used non-steroidal anti-inﬂammatory drugs (NSAIDs) (diclofenac,
ketorolac, and xefocam) on the activation of transient receptor potential (TRP) channels (TRPA1
and TRPV1) to its agonizts, allyl isothiocyanate (AITC, main compound of mustard oil), cinnamal-
dehyde (CA), and capsaicin in behavioral experiments in rats.
 We found that ketorolac pretreatment inactivates TRPA1 channels to its agonizts, AITC and CA, and
results in the return of hyperalgesia to baseline in approximately 30 minutes.
 In the same manner pretreatment with all three NSAIDs inactivates TRPV1 channel to its agonist
capsaicin.
 Our ﬁndings show for the ﬁrst time an attenuation of TRPA1 and TRPV1 activation by NSAIDs to
channel agonizts, cinnamaldehyde, mustard oil, and capsaicin in two behavioral assays.
 TRP cation channels could be investigated as promising targets for analgesic drug discovery.1. Data
Transient receptor potential (TRP) cation channels serve as cellular sensors for a wide spectrum of
physical and chemical stimuli, such as temperature, cyclic nucleotides, phosphorylation potential,
osmotic pressure, and some beneﬁcial and harmful environmental inputs [1,2,5,7,11,12].
Recent data in the ﬁeld of pain research have established a subset of thermo-TRP channels that are
capable of initiating sensory nerve impulses following the detection of thermal, as well as mechanical
and chemical irritant stimuli. These irritants include menthol, capsaicin, cinnamaldehyde (CA),
mustard oil, and others [3,4,6,8,10].
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(NSAIDs) which are speciﬁed with some side effects [9]. Here we report, using behavioral tests in rats
that one commonly used NSAIDs such as ketorolac, inactivate TRPA1 channel to enable treatment
with CA and allyl isothiocyanate (AITC), a natural compound of mustard oil (Fig. 1). In particular,
pretreatment with ketorolac resulted in a strong antinociceptive effect (Po0.001). Subsequent
injections with AITC and CA caused signiﬁcant decreases in the latency of the thermal withdrawal
reﬂex in the ipsilateral (injected) hindpaw for about ﬁrst 30–40 min (Fig. 1A). The same ﬁndings we
observed for the paw withdrawal threshold with mechanical stimulation (Fig. 1C). In approximately
40 min, the effects of CA and AITC returned to baseline. These data are different from our previous
results, where TRPA1 channel agonists CA and AITC produced hyperalgesia for nearly 2 h and facili-
tated thermal and mechanical withdrawal reﬂexes [8,10].
Concerning the TRPV1 channel we have found that three commonly used NSAIDs, such as diclo-
fenac, ketorolac, and xefocam attenuate hyperalgesia induced by TRPV1 agonist capsaicin after 40–
45 min of its injection (Fig. 2A). Equivalent ﬁndings were observed for the paw withdrawal threshold
to mechanical stimulation (Fig. 2C). In both tests, the effects of capsaicin returned to baseline in
approximately 45 min.
We suggest that presented data indicate a novel mechanism involving the anti-inﬂammatory and
analgesic effects of NSAIDs, which may be involved in direct inactivation or desensitization of TRPA1
and TRPV1 channels and could be used for development novel class of analgesics.Fig. 1. (A) Dynamics of the thermal paw withdrawal latency after ketorolac pretreatment following ipsilateral intraplantar
injection of vehicle, AITC and CA. There were signiﬁcant effects in AITC and CA groups vs. vehicle control and contralateral
(non-injected) paw (B) for the ﬁrst 30 min (P).
Fig. 2. (A) Dynamics of the thermal paw withdrawal latency after NSAIDs (clodifen, ketorolac and xefocam) pretreatment
following ipsilateral intraplantar injection of vehicle and capsaicin. There were signiﬁcant effects in capsaicin groups vs. vehicle
control and contralateral (non-injected) paw (B) for the ﬁrst 30 min (P).
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2.1. Experimental design
Behavioral measurements were performed using thermal paw withdrawal (Hargreaves) test and
mechanical paw withdrawal (von Frey) test in rodents after pretreatment their hindpaws with
NSAIDs and subsequent treatment with TRP channel agonists.
2.2. Animals
Experiments were carried out using adult male Wistar rats (350–450 g), which were singly housed
and given rodent chow and water ad libitum. The Beritashvili Experimental BMC Animal Care and Use
Committee approved the study protocol. Every effort was made to minimize both the number of
animals used and their suffering. Guidelines of the International Association for the Study of Pain
regarding animal experimentation were followed throughout [13].
2.3. Application of chemicals
AITC (15%), CA (20%), and capsaicin (0.4%) (Sigma-Aldrich, St Louis, MO, USA) or vehicle control
(mineral oil, or Tween 80, Fisher Scientiﬁc, USA) were injected intraplantar with a 30 gauge needle.
For thermal and mechanical paw withdrawal tests, AITC, CA, capsaicin, or vehicle (2 μl) was applied to
one hind paw. Twenty minutes prior to apply these TRP agonists, the same volume of NSAIDs,
diclofenac (2.5%), ketorolac (3%), and xefocam (0.4%) were injected in the same hindpaw and animals
were examined by the thermal and mechanical paw tests. Different animal groups were used for the
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vehicle and were not repeatedly used. Six rats were used for each group.
2.4. Behavioral testing
Two behavioral models were used: thermal paw withdrawal reﬂex and mechanical paw with-
drawal reﬂex (IITC, Woodland Hills, CA, USA). Prior to initiating the tests, baseline values were
assessed for the experimental and control rats for thermal and mechanical withdrawal tests, which
involved averaging ﬁve baseline measurements for the left and right hind paws with 5 min intervals.
2.4.1. Thermal paw withdrawal (Hargreaves) test
Rats were ﬁrst habituated over three successive daily sessions to stand on a glass surface heated to
3071 °C within a ventilated Plexiglas enclosure. Before formal testing, baseline latencies for paw
withdrawals evoked by radiant thermal stimulation were measured ﬁve times per paw, with at least
5 min intervals between tests of a given paw. A light beam (Plantar Test 390, IITC) was focused onto
the plantar surface of the hindpaw through a glass plate from below, and the latency from onset of
the light to brisk withdrawal of the stimulated paw was measured. To prevent potential tissue
damage, a cutoff time of 20 s was used if no paw movement occurred. Withdrawal latencies for both
the treated and untreated paws were measured 5, 15, 30, 45, 60, and 120 min after applications of
AITC, CA, capsaicin, or vehicle, to the same hindpaw.
2.4.2. Mechanical paw withdrawal (von Frey) test
Baseline mechanical withdrawal thresholds were assessed using an electronic von Frey ﬁlament
with 90 g range (1601 C, IITC) pressed against the plantar surface of one hindpaw. This device
registered the force (g) at the moment that the hindpaw was withdrawn from the ﬁlament. Following
application of AITC, CA, capsaicin, or vehicle, the mechanical paw withdrawal thresholds were
measured at the same post application times, as noted above for thermal paw withdrawals.
2.5. Data analysis
Latencies of the thermal withdrawal responses and thresholds of the mechanical responses were
normalized to baseline averages and analyzed by analysis of variance with Tukey–Kramer post-hoc
tests, using InStat 3.05 (GraphPad Software Inc., USA) software. A 95% conﬁdence interval was used
for all statistical comparisons, and the error reported is the standard error of the mean (s.e.m.).Acknowledgments
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